Atlas Trials

A Trial of Solriamfetol in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Clinical trial NCT04622293 · COMPLETED

Trial details

NCT number
NCT04622293
Sponsor
Rochester Center for Behavioral Medicine
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Fatigue SyndromeMyalgic Encephalomyelitis
Start date
2021-04-27
Primary completion
2024-09-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.